CN Patent

CN103717599A — 吲唑

Assigned to Pfizer Inc · Expires 2014-04-09 · 12y expired

What this patent protects

本发明涉及式(I)的化合物：其药学上可接受的盐及所述化合物及盐的药学上可接受的溶剂合物，其中取代基是如本文所定义；含有所述化合物的组合物；及所述化合物用于治疗各种疾病，尤其哮喘及慢性阻塞性肺病(COPD)的用途。

USPTO Abstract

本发明涉及式(I)的化合物：其药学上可接受的盐及所述化合物及盐的药学上可接受的溶剂合物，其中取代基是如本文所定义；含有所述化合物的组合物；及所述化合物用于治疗各种疾病，尤其哮喘及慢性阻塞性肺病(COPD)的用途。

Drugs covered by this patent

Patent Metadata

Patent number: CN103717599A
Jurisdiction: CN
Classification: —
Expires: 2014-04-09
Drug substance claim: No
Drug product claim: No
Assignee: Pfizer Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.